Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study

Category Primary study
JournalBlood
Year 2019
This article has no abstract
Epistemonikos ID: cd1996902f4b2eb9a36e1a490001f44e696f670b
First added on: Feb 11, 2025